Metamucil

Manufacturer: The Procter & Gamble Manufacturing Company
Effective date: 2025-10-01
Label type: HUMAN OTC DRUG LABEL
Version: 23
Source: full-release
Hydrated at: 2026-06-01 01:15:29

Label at a glance#

ProductMetamucil Therapy for regularity

Active ingredientPSYLLIUM HUSK

Label structure19 sections

Indications and uses

for relief of occasional constipation (irregularity). This product generally produces bowel movement in 12 to 72 hours.

Dosage and administration

Put one dose into an empty glass. Mix this product (child or adult dose) with at least 8 ounces (a full glass) of water or other fluid. Stir briskly and drink promptly. If mixture thickens, add more liquid and stir. For a lighter flavor experience and thinner drink, use more water. Adults 12 yrs. & older 1 packet in 8 oz of liquid at the first sign of irregularity. Can be taken up to 3 times daily. 6 – 11 yrs. 1/2...

Storage and handling

each packet (5.8 g) contains: potassium 30 mg; sodium 5 mg PHENYLKETONURICS: CONTAINS PHENYLALANINE, 25 mg per packet Store below 86º F (30º C)

Contacts and useful links#

PhoneLabel contact1-800-983-4237

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient (in each PACKET (5.8 g))

OTC - ACTIVE INGREDIENT SECTION

Psyllium husk approximately 3.4 g

Purpose

OTC - PURPOSE SECTION

Fiber laxative

Uses

INDICATIONS & USAGE SECTION

for relief of occasional constipation (irregularity). This product generally produces bowel movement in 12 to 72 hours.

• Choking:

SPL UNCLASSIFIED SECTION

Taking this product without adequate fluid may cause it to swell and block your throat or esophagus and may cause choking. Do not take this product if you have difficulty in swallowing. If you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product, seek immediate medical attention.

ALLERGY ALERT:

SPL UNCLASSIFIED SECTION

This product may cause allergic reactions in people sensitive to inhaled or ingested psyllium.

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

• abdominal pain, nausea or vomiting
• a sudden change in bowel habits persisting for 2 weeks

Ask a doctor or pharmacist before use if you

OTC - ASK DOCTOR/PHARMACIST SECTION

are taking any other drug. Take this product 2 or more hours before or after other drugs. Laxatives may affect how other drugs work.

Stop use and ask a doctor if

OTC - STOP USE SECTION

• constipation lasts more than 7 days
• rectal bleeding occurs
• you fail to have a bowel movement
These may be signs of a serious condition.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

OVERDOSAGE SECTION

In case of overdose, contact a doctor or a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Adults 12 yrs. & older

1 packet in 8 oz of liquid at the first sign of irregularity.

Can be taken up to 3 times daily.

6 – 11 yrs.

1/2 packet in 8 oz of liquid, up to 3 times daily

Under 6 yrs.

Consult a doctor

As your body adjusts to increased fiber intake, you may experience changes in bowel habits or minor bloating.

New Users:Start with 1 dose per day; gradually increase to 3 doses per day as necessary.

Other information

STORAGE AND HANDLING SECTION

each packet (5.8 g) contains:potassium 30 mg; sodium 5 mg
PHENYLKETONURICS: CONTAINS PHENYLALANINE,25 mg per packet
Store below 86º F (30º C)

Inactive ingredients

INACTIVE INGREDIENT SECTION

aspartame, citric acid, FD&C Yellow No. 6, maltodextrin, natural and artificial orange flavor

Questions?

OTC - QUESTIONS SECTION

1-800-983-4237

SPL UNCLASSIFIED SECTION

INDIVIDUAL PACKETS SEALED FOR YOUR PROTECTION

SPL UNCLASSIFIED SECTION

DIST. BY PROCTER & GAMBLE,
CINCINNATI OH 45202

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

MetaMUCIL

PSYLLIUM FIBER SUPPLEMENT THERAPY FOR REGULARITY

on-the-go!

30 packets

4-in-1 FIBER

HELPS SUPPORT:

Appetite Control*

Heart Health by Lowering Cholesterol†

Healthy Blood Sugar Levels*

Digestive Health *

SUGAR-FREE
not a low calorie food

†See back for information about soluble fiber and heart disease

ORANGE naturally and artificially flavored

30-0.21 OZ (5.8 g) POWDER PACKETS/NET WT 6.1 OZ (174g)

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

024

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
880853	Metamucil 3.4 GM Powder for Oral Suspension	PSN	23
824586	psyllium 3.4 GM Powder for Oral Suspension	PSN	23
880853	psyllium 3400 MG Powder for Oral Suspension [Metamucil]	SBD	23
824586	psyllium 3400 MG Powder for Oral Suspension	SCD	23
880853	Metamucil 3.4 GM Powder for Oral Suspension	SY	23
880853	Metamucil 3400 MG Powder for Oral Suspension	SY	23
824586	psyllium 3.4 GM Powder for Oral Suspension	SY	23

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
37000-024-01	2021-02-11	C162847	48780-1	ba0f9c33-16ef-a910-e053-dadaa90a0b85	Metamucil ® PSYLLIUM FIBER SUPPLEMENT THERAPY FOR REGULARITY on-the-go!
37000-024-02	2021-02-11	C162847	48780-1	ba0f9c33-16ef-a910-e053-dadaa90a0b85	Metamucil ® PSYLLIUM FIBER SUPPLEMENT THERAPY FOR REGULARITY on-the-go!
37000-024-04	2021-02-11	C162847	48780-1	ba0f9c33-16ef-a910-e053-dadaa90a0b85	Metamucil ® PSYLLIUM FIBER SUPPLEMENT THERAPY FOR REGULARITY on-the-go!
37000-024-06	2021-02-11	C162847	48780-1	ba0f9c33-16ef-a910-e053-dadaa90a0b85	Metamucil ® PSYLLIUM FIBER SUPPLEMENT THERAPY FOR REGULARITY on-the-go!
37000-024-07	2021-02-11	C162847	48780-1	ba0f9c33-16ef-a910-e053-dadaa90a0b85	Metamucil ® PSYLLIUM FIBER SUPPLEMENT THERAPY FOR REGULARITY on-the-go!
37000-024-08	2021-02-11	C162847	48780-1	ba0f9c33-16ef-a910-e053-dadaa90a0b85	Metamucil ® PSYLLIUM FIBER SUPPLEMENT THERAPY FOR REGULARITY on-the-go!
37000-024-10	2021-02-11	C162847	48780-1	ba0f9c33-16ef-a910-e053-dadaa90a0b85	Metamucil ® PSYLLIUM FIBER SUPPLEMENT THERAPY FOR REGULARITY on-the-go!
37000-024-44	2021-02-11	C162847	48780-1	ba0f9c33-16ef-a910-e053-dadaa90a0b85	Metamucil ® PSYLLIUM FIBER SUPPLEMENT THERAPY FOR REGULARITY on-the-go!
37000-024-01	2021-01-29	C162847	48780-1	ba0f9c33-16ef-a910-e053-dadaa90a0b85	Metamucil ® PSYLLIUM FIBER SUPPLEMENT THERAPY FOR REGULARITY on-the-go!
37000-024-02	2021-01-29	C162847	48780-1	ba0f9c33-16ef-a910-e053-dadaa90a0b85	Metamucil ® PSYLLIUM FIBER SUPPLEMENT THERAPY FOR REGULARITY on-the-go!
37000-024-04	2021-01-29	C162847	48780-1	ba0f9c33-16ef-a910-e053-dadaa90a0b85	Metamucil ® PSYLLIUM FIBER SUPPLEMENT THERAPY FOR REGULARITY on-the-go!
37000-024-06	2021-01-29	C162847	48780-1	ba0f9c33-16ef-a910-e053-dadaa90a0b85	Metamucil ® PSYLLIUM FIBER SUPPLEMENT THERAPY FOR REGULARITY on-the-go!
37000-024-07	2021-01-29	C162847	48780-1	ba0f9c33-16ef-a910-e053-dadaa90a0b85	Metamucil ® PSYLLIUM FIBER SUPPLEMENT THERAPY FOR REGULARITY on-the-go!
37000-024-08	2021-01-29	C162847	48780-1	ba0f9c33-16ef-a910-e053-dadaa90a0b85	Metamucil ® PSYLLIUM FIBER SUPPLEMENT THERAPY FOR REGULARITY on-the-go!
37000-024-10	2021-01-29	C162847	48780-1	ba0f9c33-16ef-a910-e053-dadaa90a0b85	Metamucil ® PSYLLIUM FIBER SUPPLEMENT THERAPY FOR REGULARITY on-the-go!
37000-024-44	2021-01-29	C162847	48780-1	ba0f9c33-16ef-a910-e053-dadaa90a0b85	Metamucil ® PSYLLIUM FIBER SUPPLEMENT THERAPY FOR REGULARITY on-the-go!

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
37000-024-04	MetamucilTherapy for regularity	30 in 1 CARTON	POWDER	30	23
37000-024-04	MetamucilTherapy for regularity	5.8 g in 1 PACKET	POWDER	5.8	23
37000-024-10	MetamucilTherapy for regularity	5.8 g in 1 PACKET	POWDER	5.8	23

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
37000-024-01	GM - Gram	37000-024	e08d39d6-52ab-4673-aa56-b98c215a4efb	1	2015-11-12
37000-024-04	EA - Each	37000-024	35398180-dc8a-4820-9b5a-d060ea649f68	1	2015-07-20
37000-024-10	EA - Each	37000-024	2cb2c2e7-071b-4d7d-a723-fce476ee6a2b	1	2018-02-20

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Psyllium Husk	ACTIVE INGREDIENT	0SHO53407G	3
Psyllium Husk	ACTIVE MOIETY	0SHO53407G	3
aspartame	INACTIVE INGREDIENT	Z0H242BBR1	3
citric acid monohydrate	INACTIVE INGREDIENT	2968PHW8QP	3
FD&C Yellow No. 6	INACTIVE INGREDIENT	H77VEI93A8	3
maltodextrin	INACTIVE INGREDIENT	7CVR7L4A2D	3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

Metamucil Therapy for regularity
Psyllium Husk
CITRIC ACID MONOHYDRATE
ASPARTAME
FD&C YELLOW NO. 6
MALTODEXTRIN

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
37000-024	37000-024-04, 37000-024-10

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
CITRIC ACID MONOHYDRATE	2968PHW8QP	IACT
ASPARTAME	Z0H242BBR1	IACT
FD&C YELLOW NO. 6	H77VEI93A8	IACT
MALTODEXTRIN	7CVR7L4A2D	IACT
PSYLLIUM HUSK	0SHO53407G	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 54 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET, CHEWABLE / ORAL	292 mg		Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET, EXTENDED RELEASE / ORAL		3239 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET, ORALLY DISINTEGRATING / ORAL		12 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	CAPSULE / ORAL		200 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET, COATED / ORAL	5.6 mg		Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	PASTE / ORAL		1050 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	SOLUTION / ORAL		1451 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	PASTE / ORAL		1050 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET, COATED / ORAL	5.6 mg		Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	SUSPENSION / ORAL		6040 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET, CHEWABLE / ORAL	292 mg		Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	GRANULE, FOR SUSPENSION / ORAL		952 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	POWDER, FOR SUSPENSION / ORAL		8000 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	GRANULE, FOR SUSPENSION / ORAL		952 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	POWDER, FOR SUSPENSION / ORAL		8000 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii+route 45 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	POWDER / ORAL		840 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	GRANULE, FOR SUSPENSION / ORAL		952 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	CAPSULE / ORAL		200 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	FILM, SOLUBLE / ORAL		19 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET, EFFERVESCENT / ORAL		14404 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET, ORALLY DISINTEGRATING / ORAL		12 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii+route 45 equally ranked IID candidates
aspartame	ASPARTAME	Z0H242BBR1	POWDER / ORAL		63 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET, EFFERVESCENT / ORAL		14404 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET, EFFERVESCENT / ORAL		14404 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	PASTE / ORAL		1050 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET, CHEWABLE / ORAL	292 mg		Exact identifier — unii+route 45 equally ranked IID candidates
FD&C Yellow No. 6	FD&C YELLOW NO. 6	H77VEI93A8	POWDER / ORAL	20 mg		Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
FD&C Yellow No. 6	FD&C YELLOW NO. 6	H77VEI93A8	POWDER / ORAL	20 mg		Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	SOLUTION / ORAL		1451 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	FILM, SOLUBLE / ORAL		19 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	LOZENGE / ORAL		175 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET, COATED / ORAL	5.6 mg		Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET / ORAL		320 mg	Exact identifier — unii+route 45 equally ranked IID candidates
aspartame	ASPARTAME	Z0H242BBR1	POWDER / ORAL		63 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	CAPSULE / ORAL		200 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	SUSPENSION / ORAL		6040 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	FILM, SOLUBLE / ORAL		19 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	POWDER, FOR SUSPENSION / ORAL		8000 mg	Exact identifier — unii+route 45 equally ranked IID candidates
FD&C Yellow No. 6	FD&C YELLOW NO. 6	H77VEI93A8	POWDER / ORAL	20 mg		Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	LOZENGE / ORAL		175 mg	Exact identifier — unii+route 45 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	POWDER / ORAL		840 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	LOZENGE / ORAL		175 mg	Exact identifier — unii+route 45 equally ranked IID candidates
aspartame	ASPARTAME	Z0H242BBR1	POWDER / ORAL		63 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET, EXTENDED RELEASE / ORAL		3239 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET / ORAL		320 mg	Exact identifier — unii+route 45 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	POWDER / ORAL		840 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET, EXTENDED RELEASE / ORAL		3239 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	SOLUTION / ORAL		1451 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	SUSPENSION / ORAL		6040 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET / ORAL		320 mg	Exact identifier — unii+route 45 equally ranked IID candidates
maltodextrin	MALTODEXTRIN	7CVR7L4A2D	TABLET, ORALLY DISINTEGRATING / ORAL		12 mg	Exact identifier — unii+route 45 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Metamucil Therapy for regularity	PSYLLIUM HUSK	The Procter & Gamble Manufacturing Company	a9824f73-5ea2-4a65-a926-3a57561441b8	2025-10-01	Warnings	Exact identifier ndc (package): 37000-024-04 ndc (package): 37000-024-10 ndc (product): 37000-024 ndc11 (package): 37000002404 ndc11 (package): 37000002410 spl id: 401e2c29-621f-6e6d-e063-6394a90a8d7d spl set id: a9824f73-5ea2-4a65-a926-3a57561441b8

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.